2013 CRTI Summer Workshop

2013年CRTI夏季研讨会

基本信息

  • 批准号:
    8589126
  • 负责人:
  • 金额:
    $ 4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The American Society of Hematology (ASH) Clinical Research Training Institute (CRTI) was initiated in 2003 and prepares fellows and junior faculty to conduct patient-oriented clinical research in all areas of hematology, including the hematological malignancies (leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, myeloproliferative neoplasms) and non-malignant hematology (bleeding and clotting disorders and diseases of red blood cells). Having a physician workforce prepared to conduct this research is critical to translating developments in laboratory and pre-clinical research to th care of patients and populations. CRTI is a year-long program that includes a week-long Summer Workshop, ongoing mentoring, and two follow-up meetings. This application requests support for the 2013 CRTI Summer Workshop, which is the "kick-off" event for the 20 fellows and junior faculty who will be trained in the program. The goals of the Summer Workshop are to provide participants feedback on their research proposals, build professional networks among the participants and faculty, and identify mentors who will work with the participants over the course of the following year to ensure the investment in the CRTI experience is well utilized. The Summer Workshop includes at least as many faculty instructors as participants, and it features national and international experts in hematology, clinical trial design, and biostatistics The week-long program includes interactive didactic sessions, small group breakouts, and time for informal interactions. ASH undertakes a multi-pronged strategy to ensure the appropriate representation of women and minority participants in both the participant and faculty groups. The strategy for participants includes initial outreach to secure the largest possible pool of female and minority applicants as well as focused discussions about diversity goals during the finalist selection process. Female and minority faculty are likewise actively identified from among past program participants and through the network of past and current CRTI faculty. The CRTI Summer Workshop is evaluated by the participants. Results of the 2012 CRTI Summer Workshop post-workshop evaluation indicate the event was successful in providing very helpful recommendations on the proposed research plans (100% of participants); 100% of participants indicated they are very likely to recommend CRTI to peers. The entirety of the program is also systematically evaluated. Of the 140 CRTI participants from 2003-2009 surveyed in 2010, 87% stated they had been successful in establishing a patient-oriented clinical research study, 85% considered themselves to be clinical investigators, and 90% were conducting research as part of their current jobs. Approximately 40% had an ongoing collaboration with a CRTI mentor. CRTI participants have been extremely productive, with over 1,000 peer-reviewed publications, 170 book chapters, and 100 review articles amongst them. They have earned 78 NIH grants as principal investigators.
描述(由申请人提供):美国血液学会 (ASH) 临床研究培训机构 (CRTI) 成立于 2003 年,旨在培养研究员和初级教员,在血液学的所有领域开展以患者为导向的临床研究,包括血液恶性肿瘤(白血病、淋巴瘤、多发性骨髓瘤、骨髓增生异常综合征、骨髓增生性肿瘤)和非恶性血液学(出血和凝血障碍和红细胞疾病)。拥有一支准备好进行这项研究的医生队伍对于将实验室和临床前研究的发展转化为患者和人群的护理至关重要。 CRTI 是一个为期一年的计划,包括为期一周的夏季研讨会、持续指导和两次后续会议。此申请请求支持 2013 年 CRTI 夏季研讨会,该研讨会是 20 名将接受该计划培训的研究员和初级教员的“启动”活动。夏季研讨会的目标是向参与者提供有关其研究计划的反馈,在参与者和教师之间建立专业网络,并确定在接下来的一年中与参与者合作的导师,以确保对 CRTI 经验的投资很好利用。夏季研讨会的教职人员数量至少与参与者一样多,并且有血液学、临床试验设计和生物统计学方面的国内和国际专家。为期一周的课程包括互动教学课程、小组分组讨论和非正式互动时间。 ASH 采取多管齐下的战略,确保女性和少数族裔参与者在参与者和教职员工群体中拥有适当的代表性。参与者的策略包括进行初步宣传,以确保尽可能多的女性和少数族裔申请者,以及在决赛入围者选拔过程中集中讨论多样性目标。同样,女性和少数族裔教职人员也是从过去的项目参与者中以及通过过去和现任 CRTI 教职人员网络积极甄别出来的。 CRTI 夏季研讨会由参与者进行评估。 2012 年 CRTI 夏季研讨会会后评估结果表明,该活动成功地为拟议的研究计划提供了非常有帮助的建议(100% 的参与者); 100% 的参与者表示他们非常有可能向同行推荐 CRTI。整个计划也经过系统评估。 2010 年调查的 2003 年至 2009 年期间的 140 名 CRTI 参与者中,87% 表示他们已成功建立以患者为导向的临床研究,85% 认为自己是临床研究者,90% 正在将研究作为当前研究的一部分。工作机会。大约 40% 的人与 CRTI 导师持续合作。 CRTI 参与者的生产力极高,发表了 1,000 多种同行评审出版物、170 个书籍章节和 100 篇评论文章。他们作为主要研究人员获得了 78 项 NIH 资助。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julie A Panepinto其他文献

The number of people with sickle‐cell disease in the United States: national and state estimates
美国镰状细胞病患者人数:国家和州估计

Julie A Panepinto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julie A Panepinto', 18)}}的其他基金

Quality of Life After Treatment with Magnesium for Acute Sickle Cell Pain Episode
镁治疗急性镰状细胞疼痛发作后的生活质量
  • 批准号:
    8078458
  • 财政年份:
    2011
  • 资助金额:
    $ 4万
  • 项目类别:
Quality of Life After Treatment with Magnesium for Acute Sickle Cell Pain Episode
镁治疗急性镰状细胞疼痛发作后的生活质量
  • 批准号:
    8213521
  • 财政年份:
    2011
  • 资助金额:
    $ 4万
  • 项目类别:
Quality of Life After Treatment with Magnesium for Acute Sickle Cell Pain Episode
镁治疗急性镰状细胞疼痛发作后的生活质量
  • 批准号:
    8389606
  • 财政年份:
    2011
  • 资助金额:
    $ 4万
  • 项目类别:
Quality of Life Children With Sickle Cell Disease
镰状细胞病儿童的生活质量
  • 批准号:
    7127598
  • 财政年份:
    2005
  • 资助金额:
    $ 4万
  • 项目类别:
Quality of Life Children With Sickle Cell Disease
镰状细胞病儿童的生活质量
  • 批准号:
    6906764
  • 财政年份:
    2005
  • 资助金额:
    $ 4万
  • 项目类别:
Quality of Life Children With Sickle Cell Disease
镰状细胞病儿童的生活质量
  • 批准号:
    7489934
  • 财政年份:
    2005
  • 资助金额:
    $ 4万
  • 项目类别:
SILENT INFARCT TRANSFUSION TRIAL
无声梗塞输血试验
  • 批准号:
    7375113
  • 财政年份:
    2005
  • 资助金额:
    $ 4万
  • 项目类别:
Quality of Life Children With Sickle Cell Disease
镰状细胞病儿童的生活质量
  • 批准号:
    7282010
  • 财政年份:
    2005
  • 资助金额:
    $ 4万
  • 项目类别:
Quality of Life Children With Sickle Cell Disease
镰状细胞病儿童的生活质量
  • 批准号:
    7682552
  • 财政年份:
    2005
  • 资助金额:
    $ 4万
  • 项目类别:
Patient services: Development of the PedsQL Sickle Cell Disease Module
患者服务:PedsQL 镰状细胞病模块的开发
  • 批准号:
    8261336
  • 财政年份:
  • 资助金额:
    $ 4万
  • 项目类别:

相似国自然基金

基于lncRNA NONHSAT042241/hnRNP D/β-catenin轴探讨雷公藤衍生物(LLDT-8)对类风湿关节炎滑膜成纤维细胞功能影响及机制研究
  • 批准号:
    82304988
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
针刺手法和参数对针刺效应启动的影响及其机制
  • 批准号:
    82305416
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
二仙汤影响肾上腺皮质-髓质激素分泌及调控下丘脑温度感受器以缓解“天癸竭”潮热的研究
  • 批准号:
    82374307
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
固定翼海空跨域航行器出水稳定性与流体动力载荷影响机制
  • 批准号:
    52371327
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
经济制裁对跨国企业海外研发网络建构的影响:基于被制裁企业的视角
  • 批准号:
    72302155
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
  • 批准号:
    10751106
  • 财政年份:
    2024
  • 资助金额:
    $ 4万
  • 项目类别:
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
停止使用羟氯喹治疗老年狼疮病 (SHIELD)
  • 批准号:
    10594743
  • 财政年份:
    2023
  • 资助金额:
    $ 4万
  • 项目类别:
Identifying and testing a tailored strategy to achieve equity in blood pressure control in PACT
确定并测试量身定制的策略,以在 PACT 中实现血压控制的公平性
  • 批准号:
    10538513
  • 财政年份:
    2023
  • 资助金额:
    $ 4万
  • 项目类别:
The Effects of the Medicaid Continuous Coverage Requirement during the Public Health Emergency on Postpartum Coverage and Maternal and Infant Care after Childbirth
突发公共卫生事件期间医疗补助持续覆盖要求对产后覆盖和产后母婴护理的影响
  • 批准号:
    10643130
  • 财政年份:
    2023
  • 资助金额:
    $ 4万
  • 项目类别:
The Role of Layilin as a Novel Regulator of Platelet Activation and Thromboinflammation
Layilin 作为血小板活化和血栓炎症的新型调节剂的作用
  • 批准号:
    10638243
  • 财政年份:
    2023
  • 资助金额:
    $ 4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了